Biology of Human Ovarian Cancer Xenografts

  • E. Boven
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

In an attempt to establish human ovarian cancer tissue samples as subcutaneous xenografts in athymic (nu/nu) mice, our overall take rate was 32% and 11% of all specimens could be transferred beyond 3 passages. Transplantability was most successful if samples were derived from a metastatic lesion, contained a high number of mitotic figures and were not infiltrated by lymphocytes. The take rate was not dependent on the histologic subtype or the degree of differentiation.

All tumor lines thus far in use for chemotherapy studies have retained the histologic pattern of origin and have a consistent growth rate. At present our human ovarian cancer model contains a series of lines which vary in histologic subtype and tumor doubling time, differences that may also be expected in a group of ovarian cancer patients.

Keywords

Ovarian Cancer Histologic Subtype Alcian Blue Mitotic Figure Ovarian Cancer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Houghton JA and Taylor DM: Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer 1978 (37): 199–212PubMedCrossRefGoogle Scholar
  2. 2.
    Kovnat A, Buick RN, Connolly JG, Jewett MA, Keresteci AG and Tannock IF: Comparison of growth of human bladder cancer in tissue culture or as a xenograft with clinical and pathological characteristics. Cancer Res 1984 (44): 2530–2533PubMedGoogle Scholar
  3. 3.
    Friedlander ML, Russel P, Taylor IW and Tattersall MHN: Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer. Br J Cancer 1985 (51): 319–333PubMedCrossRefGoogle Scholar
  4. 4.
    Boven E: Human ovarian xenografts in nude mice. Application of a new model in the selection of novel agents for ovarian cancer. Amsterdam: Rodopi 1986Google Scholar
  5. 5.
    Kullander S, Rausing A and Trope C: Human ovarian tumors heterotransplanted to “nude” mice. Acta Obstet Gynecol Scand 1978 (57): 149–159PubMedCrossRefGoogle Scholar
  6. 6.
    Nauta MM, Boven E, Schlueper HMM, Erkelens CAM and Pinedo HM: Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice. Br J Cancer 1986 (54): 331–335PubMedCrossRefGoogle Scholar
  7. 7.
    Beattie GM, Knowles AF, Jensen FC, Baird SM and Kaplan NO: Induction of sarcomas in athymic mice. Proc Natl Acad Sci USA 1982 (79): 3033–3036PubMedCrossRefGoogle Scholar
  8. 8.
    Fodstad ø, Rofstad EK, Tveit KM and Pihl A: Spontaneous alteration in growth rate of two human melanoma xenografts. Concurrent change in chemosensitivity. Eur J Cancer Clin Oncol 1983 (19): 1175–1178Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • E. Boven
    • 1
  1. 1.Department of OncologyFree University HospitalAmsterdamThe Netherlands

Personalised recommendations